INFO & CONTACTS:  +39 02 2390 1

Breast Surgery Unit

Milano
Via Giacomo Venezian, 1 , 20133 Milano MI

dott. Mattia Intra

Dr. Intra Mattia

Director of the Complex Unit

Typology: Clinical Area, Complex Structure

The Breast Surgery Unit of the Fondazione IRCCS Istituto Nazionale dei Tumori di Milano builds on one of the most important Italian and international traditions in the treatment of breast cancer.

It was at this Institute that some of the innovations that profoundly changed the history of modern breast cancer care were developed, beginning with breast-conserving surgery and the clinical trials that progressively reduced the extent of treatment while maintaining — and improving — oncological outcomes.

Today, this legacy provides the foundation for a Breast Unit that combines surgical excellence, multidisciplinary care, innovation, research, and a strong focus on patients’ quality of life.

The Breast Surgery Unit manages the full spectrum of surgical breast conditions, including malignant and benign tumors, rare and mesenchymal tumors, breast disease in men, and individuals at high hereditary or familial risk of developing breast cancer.

Our aim is to provide every patient with a personalized and timely pathway based on the best available scientific evidence, reducing the burden of treatment whenever possible without compromising oncological effectiveness.

Breast cancer treatment requires the integration of multiple areas of expertise.

For this reason, every stage of the patient pathway is developed in close collaboration with:

  • Medical Oncology
  • Breast Imaging
  • Interventional Radiology
  • Nuclear Medicine
  • Radiation Oncology
  • Pathology and Molecular Pathology
  • Plastic and Reconstructive Surgery
  • Medical Genetics
  • Psycho-Oncology
  • Rehabilitation and Supportive Care

Cases are discussed within the multidisciplinary Breast Unit in order to define, collectively, the most appropriate diagnostic and therapeutic strategy for each patient.

The availability within INT of highly specialized expertise, together with advanced diagnostic and molecular technologies, makes it possible to manage even particularly complex clinical situations.

The Unit performs the full range of breast cancer surgical procedures, following a fundamental principle of contemporary breast surgery: to achieve the best possible oncological outcome with the least invasive treatment required for each individual patient.

Our surgical activity includes:

  • breast-conserving surgery;
  • oncoplastic breast surgery;
  • mastectomy and conservative mastectomy techniques;
  • axillary lymph node surgery;
  • sentinel lymph node biopsy and axillary de-escalation strategies;
  • surgery following neoadjuvant systemic treatment;
  • surgery for non-palpable breast lesions;
  • prophylactic and risk-reducing surgery in women with genetic predisposition;
  • immediate or delayed breast reconstruction in collaboration with the Plastic and Reconstructive Surgery Unit;
  • surgical treatment of male breast cancer;
  • treatment of breast sarcomas and other rare breast tumors;
  • treatment of locally advanced disease and highly complex cases.

Particular attention is devoted to preserving body image, achieving high-quality reconstructive outcomes, and maintaining quality of life after treatment.

One of the strategic objectives of the Unit is the development of an advanced Day Surgery programme dedicated to breast surgery.

Advances in surgical, anaesthetic and perioperative techniques now allow an increasing proportion of breast procedures to be performed through short-stay or same-day pathways while maintaining high standards of safety and quality of care.

The programme is based on close integration between surgeons, anaesthesiologists, radiologists, nuclear medicine specialists, nurses and all healthcare professionals involved in the perioperative pathway.

The objective is not simply to shorten hospital stay, but to develop a patient-centred organizational model that promotes early recovery, appropriateness of care and continuity of treatment.

Alongside conventional breast cancer surgery, the Unit has developed dedicated pathways for specific clinical conditions in which the multidisciplinary expertise available within INT allows for a particularly high level of specialization.

Male Breast Cancer

Male breast cancer is a rare disease that requires a specific approach.

INT has developed a dedicated multidisciplinary pathway integrating expertise in breast surgery, medical oncology, genetics, andrology, sexual medicine and plastic surgery.

Women at High Genetic Risk

Women carrying genetic variants associated with a high risk of breast cancer can access an integrated pathway including genetic counselling, surveillance, psychological support and assessment of potential risk-reducing surgical strategies.

Breast Sarcomas and Rare Tumors

The Institute’s multidisciplinary oncological expertise allows patients with rare and mesenchymal breast tumors to be managed through highly specialized pathways.

Complex Clinical Cases

Dedicated pathways are also available for patients with particularly complex oncological or surgical conditions requiring the integration of multiple specialist teams within the Institute.

Research and clinical care are inseparable components of the Unit’s activity.

Particular emphasis is placed on clinical and translational research, with the aim of rapidly transferring discoveries generated within INT laboratories and research platforms into clinical practice.

Collaboration with Pathology and Molecular Pathology represents a strategic resource for the development of increasingly personalized approaches to breast cancer treatment.

The Unit participates in monocentric, national and international clinical trials and promotes new research projects focusing, among other areas, on:

  • surgical treatment de-escalation;
  • axillary management;
  • integration of surgery and systemic therapy;
  • management of disease following neoadjuvant treatment;
  • innovative locoregional treatments;
  • cryoablation and other ablative therapies;
  • metastatic breast cancer;
  • rare breast tumors;
  • quality of life and patient-reported outcomes;
  • organizational models and Day Surgery.

When appropriate, patients are offered the opportunity to participate in controlled clinical trials providing access to innovative diagnostic and therapeutic strategies.

Treating cancer means caring not only for the disease, but for the person as a whole.

The Unit places particular emphasis on quality of life both during and after treatment through dedicated rehabilitation pathways, psychological support, prevention and treatment of lymphoedema, symptom management and lifestyle interventions.

Our aim is to accompany patients throughout their entire journey, from diagnosis and treatment to their return to personal, family and professional life.

The INT Breast Surgery Unit provides education, training and tutoring for physicians and healthcare professionals and collaborates with universities, scientific societies and national and international institutions.

Particular attention is devoted to the education of the next generation of specialists and to the development of advanced multidisciplinary training programmes in breast cancer care.

The Unit collaborates, among others, with the University of Milan and with national and international scientific societies involved in breast cancer treatment and research.

The Breast Surgery Unit of the Istituto Nazionale dei Tumori aims to remain a place where history, research and clinical innovation come together.

Over the coming years, our objective is to further develop clinical activity, Day Surgery, clinical and translational research, education and highly specialized areas of care, strengthening INT’s role as a national and international referral centre for breast cancer.

A Breast Surgery Unit capable of preserving an extraordinary heritage without living in the past, transforming that heritage into the energy needed to shape the future.

Segreteria

Note: dal lunedì al venerdì dalle 9.00 alle 16.00

Orari di accesso visite ai degenti: 16:00-18:00

Orari di accesso informatori scientifici: Su appuntamento, il lunedì dalle 14 alle 15. 

Dott. Intra Mattia
Director of the Complex Unit

Dott.ssa Ferraris Cristina
Medical Director

Dott. Gennaro Massimiliano
Medical Director

Dott.ssa Listorti Chiara
Medical Director

Dott. Martelli Gabriele
Medical Director

Dott.ssa Osio Chiara
Medical Director

Dott.ssa Pilotta Federica
Medical Director

Dott.ssa Maugeri Ilaria
Medical Director

Dott.ssa Bonfili Deborah
Contract Physician

Dott. Agresti Roberto
Medical Director

Contrattisti:

  • Visaggio Marco 

Coordinatrice Inferimeristica: 

  • Gentilini Cinzia 

Personale amministrativo, segreteria: 

  • Aceto Roberta

Omission of local therapies in women patients with HER2-positive or triple-negative breast cancer. A two arm, phase 2, non-inferiority trial for surveillance in maximum responders to neoadjuvant systemic therapy.

Last update: 29/09/2026

Subscribe to the newsletter

Sign up for our newsletter to stay informed about news, events, and updates from the Institute

Subscribe